Completed NA INTERVENTIONAL 1-arm NCT05239572

Scaling Up NCD Interventions in South East Asia (SUNI-SEA)

Scaling Up Non-Communicable Diseases Interventions in South East Asia

Sponsor: Health Strategy and Policy Institute

Conditions Cardiovascular Diseases Diabetes Mellitus, Type 2 Hypertension

Interventions screening, prevention and counselling

Updated 6 times since 2022 Last updated: Oct 26, 2023 Started: Mar 31, 2022 Primary completion: Jun 30, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Diseases and Diabetes Mellitus, Type 2 and is currently completed. Health Strategy and Policy Institute leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2022 — Nov 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2022 — Jun 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Mar 2022 — Apr 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Health Strategy and Policy Institute
HelpAge International
Thai Nguyễn University of Medicine and Pharmacy
Trnavska Universita v Trnava
Universitas Sebelas Maret
University Medical Center Groningen
University of Groningen
University of Passau

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hanoi, Vietnam